Connect to other sites within the UBM Medica Network
FDA Drug Approvals for Cancer in 2016
This slide show highlights 2016 FDA approvals of cancer treatments, which to date include therapies for RCC, neuroendocrine tumors, Hodgkin lymphoma, CLL, sarcoma, bladder cancer, lung cancer, and breast cancer.
Not Enough Evidence to Balance Harms, Benefit of Visual Skin Cancer Exam
There is currently not enough evidence to assess the balance of benefits and harms of a visual skin examination by a clinician to screen for skin cancer in asymptomatic adults.
Nephrectomy for RCC May Result in Significant Declines in Renal Function
Patients with RCC had greater postsurgical decreases in kidney function compared with patients with upper tract urothelial carcinoma.
Robotic Surgery On Par With Non-Robotic Surgery for Prostate Cancer
Robot-assisted and open radical surgeries for prostate cancer have similar outcomes for patients at 3 months, according to clinical trial results.
Finding the Mechanisms of Immunotherapy Resistance
In this interview we discuss a recent study that identified genetic mechanisms of immunoresistance to treatment with anti-PD-1 antibodies.
Bronchial Mass Discovered in 47-Year-Old Patient
A 47-year-old man presents with a cough and dyspnea. A bronchial mass in found, and a biopsy is performed. What is your diagnosis?
Delirium Common in Advanced Cancer Patients Visiting ER
Ten percent of advanced cancer patients have developed delirium, but it is often missed by emergency department physicians.
Pancreatic Mass Found in 43-Year-Old Patient
A 43-year-old woman presents with abdominal pain. Imaging detects a mass in the pancreas, and a biopsy is performed. What is your diagnosis?
Selinexor Shows Promise in Phase I Sarcoma Trial
A phase I trial of selinexor found the drug was reasonably well tolerated and showed some activity in patients with advanced soft-tissue or bone sarcoma with progressive disease.
Push for Molecular Profiling Could Transform Advanced Bladder Cancer Care
New NCCN guidelines regarding genomic profiling will likely yield important opportunities to improve the care of patients with advanced bladder cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.